End-of-day quote
Buenos Aires S.E.
18:00:00 2024-05-19 EDT
|
5-day change
|
1st Jan Change
|
33.25
ARS
|
+2.94%
|
|
+6.91%
|
+134.98%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
918.8
|
829.9
|
2,729
|
2,281
|
3,264
|
15,446
|
Enterprise Value (EV)
1 |
728.1
|
596.8
|
2,332
|
1,722
|
2,444
|
13,028
|
P/E ratio
|
4.05
x
|
17.8
x
|
35.6
x
|
-53.8
x
|
-10.7
x
|
100
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.26
x
|
1.81
x
|
4.88
x
|
2.85
x
|
2.35
x
|
3.27
x
|
EV / Revenue
|
2.58
x
|
1.3
x
|
4.17
x
|
2.15
x
|
1.76
x
|
2.76
x
|
EV / EBITDA
|
11.6
x
|
5.3
x
|
16.9
x
|
12.7
x
|
50.2
x
|
33
x
|
EV / FCF
|
-2.56
x
|
-1.05
x
|
-274
x
|
181
x
|
-66.1
x
|
-13.7
x
|
FCF Yield
|
-39.1%
|
-95.4%
|
-0.36%
|
0.55%
|
-1.51%
|
-7.31%
|
Price to Book
|
5.34
x
|
1.92
x
|
2.35
x
|
1.34
x
|
1.09
x
|
1.63
x
|
Nbr of stocks (in thousands)
|
592,753
|
592,753
|
1,091,624
|
1,091,624
|
1,091,624
|
1,091,624
|
Reference price
2 |
1.550
|
1.400
|
2.500
|
2.090
|
2.990
|
14.15
|
Announcement Date
|
19-03-01
|
20-02-13
|
21-02-17
|
22-03-01
|
23-02-14
|
24-02-09
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
281.8
|
458.7
|
558.9
|
799.9
|
1,391
|
4,722
|
EBITDA
1 |
62.76
|
112.6
|
138.1
|
135.6
|
48.65
|
394.7
|
EBIT
1 |
35.76
|
72.58
|
83.24
|
43.18
|
-136.5
|
-125.5
|
Operating Margin
|
12.69%
|
15.82%
|
14.89%
|
5.4%
|
-9.81%
|
-2.66%
|
Earnings before Tax (EBT)
1 |
43.16
|
112.3
|
113
|
28.78
|
-135.3
|
678.9
|
Net income
1 |
223.1
|
78.65
|
76.75
|
-42.41
|
-306.4
|
154.4
|
Net margin
|
79.18%
|
17.15%
|
13.73%
|
-5.3%
|
-22.03%
|
3.27%
|
EPS
2 |
0.3826
|
0.0785
|
0.0703
|
-0.0388
|
-0.2807
|
0.1415
|
Free Cash Flow
1 |
-284.8
|
-569.3
|
-8.51
|
9.511
|
-36.95
|
-952.6
|
FCF margin
|
-101.06%
|
-124.12%
|
-1.52%
|
1.19%
|
-2.66%
|
-20.18%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
7.01%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-03-01
|
20-02-13
|
21-02-17
|
22-03-01
|
23-02-14
|
24-02-09
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
191
|
233
|
397
|
560
|
820
|
2,419
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-285
|
-569
|
-8.51
|
9.51
|
-37
|
-953
|
ROE (net income / shareholders' equity)
|
-34.6%
|
18.8%
|
10.7%
|
-2.8%
|
-5.4%
|
2.93%
|
ROA (Net income/ Total Assets)
|
3.31%
|
3.97%
|
3.35%
|
1.14%
|
-1.95%
|
-0.58%
|
Assets
1 |
6,744
|
1,981
|
2,288
|
-3,704
|
15,681
|
-26,669
|
Book Value Per Share
2 |
0.2900
|
0.7300
|
1.060
|
1.560
|
2.750
|
8.680
|
Cash Flow per Share
2 |
0.3200
|
0.2100
|
0.3600
|
0.5100
|
0.7500
|
2.220
|
Capex
1 |
20
|
70.4
|
85.3
|
85.5
|
134
|
1,367
|
Capex / Sales
|
7.09%
|
15.34%
|
15.27%
|
10.69%
|
9.6%
|
28.96%
|
Announcement Date
|
19-03-01
|
20-02-13
|
21-02-17
|
22-03-01
|
23-02-14
|
24-02-09
|
|
1st Jan change
|
Capi.
|
---|
| +134.98% | 40.84M | | +4.85% | 105B | | -5.99% | 62.52B | | +72.86% | 49.08B | | +15.33% | 38.99B | | +5.22% | 32.59B | | +13.53% | 20.6B | | +12.59% | 17.19B | | +18.15% | 15.13B | | +3.29% | 14.36B |
Other Commodity Chemicals
|